Lind Global Fund II LP 13D and 13G filings for ABVC BioPharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-08-07 4:01 pm Purchase |
2023-07-28 | 13G | ABVC BioPharma, Inc. ABVC |
Lind Global Fund II LP | 385,000 9.900% |
385,000 (New Position) |
Filing |